2019

October 9, 2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures | READ MORE


2018

November 14, 2018
ImmunoMolecular Therapeutics Awarded SBIR Grant and Receives Rare Pediatric Disease Designation from FDA for IMT-002 | READ MORE

June 25, 2018
ImmunoMolecular Therapeutics’ Scientific Co-founder Presents a Novel Small Molecule Approach to Blocking the Autoimmunity in Type 1 Diabetes | READ MORE

February 15, 2018
ImmunoMolecular Therapeutics Announces Publication of a Novel Small Molecule Approach to Blocking the Autoimmunity in Type 1 Diabetes | READ MORE


2017

December 21, 2017
ImmunoMolecular Therapeutics To Present at the 10th Annual Biotech Showcase | READ MORE

December 6, 2017
ImmunoMolecular Therapeutics Announces Two Issued Patents For Small Molecule Therapies in Type 1 Diabetes and Celiac Disease | READ MORE

November 9, 2017
ImmunoMolecular Therapeutics Launches to Advance Innovative Immunotherapies for Genetically Defined Type 1 Diabetes and Other Autoimmune Diseases | READ MORE